High-Intensity-Focused Ultrasound for Prostate Cancer

Prostate cancer is the most common cancer in males and the second-leading cancer-related cause of death in the Western world. Prostate-specific antigen (PSA) screening, and changes in the diagnostic pathway of prostate cancer, has resulted in proportionally more men being diagnosed with early stage prostate cancer still confined to the prostate. Patients are faced with an overwhelming choice of treatment options to treat their disease. Standard options include radical prostatectomy (RP) and external-beam radiotherapy (ERBT) which, although provide good long-term cancer control, are associated with significant side effects affecting the quality of life of these patients.

[1]  J. Eastham,et al.  High‐intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure , 2009, BJU international.

[2]  Rajiv Chopra,et al.  MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. , 2012, Radiology.

[3]  M Emberton,et al.  High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series , 2009, British Journal of Cancer.

[4]  A. Bohle.  Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients , 2011 .

[5]  S. Horie,et al.  Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. , 2008, Japanese journal of clinical oncology.

[6]  Tetsutaro Hayashi,et al.  Transrectal high‐intensity focused ultrasound for treatment of localized prostate cancer , 2011, International journal of urology : official journal of the Japanese Urological Association.

[7]  A. Haese*,et al.  Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer , 2006, World Journal of Urology.

[8]  H. Saint-Jalmes,et al.  MR monitoring of tumour thermal therapy , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[9]  G E Hanks,et al.  Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. J. de la Rosette,et al.  Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. , 1999, Urology.

[11]  H. Ahmed,et al.  Focal therapy for localized prostate cancer: a phase I/II trial. , 2011, The Journal of urology.

[12]  F. Staerman,et al.  Six years’ experience with high‐intensity focused ultrasonography for prostate cancer: oncological outcomes using the new ‘Stuttgart’ definition for biochemical failure , 2011, BJU international.

[13]  Louis Potters,et al.  12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. , 2005, The Journal of urology.

[14]  M. Gallucci,et al.  Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development Study. , 2015, European urology.

[15]  Constantin Coussios,et al.  High intensity focused ultrasound: Physical principles and devices , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  T. Uchida,et al.  Quality of life following high‐intensity focused ultrasound for the treatment of localized prostate cancer: A prospective study , 2010, International journal of urology : official journal of the Japanese Urological Association.

[17]  S. Crouzet,et al.  Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. , 2014, European urology.

[18]  S. Crouzet,et al.  Hemi salvage high‐intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two‐centre study , 2014, BJU international.

[19]  P. Carroll,et al.  Treatment failure after primary and salvage therapy for prostate cancer , 2008, Cancer.

[20]  J. Chapelon,et al.  Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI , 2009, European Radiology.

[21]  P. Schellhammer,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[22]  A. Gelet,et al.  Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry , 2012, Prostate Cancer and Prostatic Diseases.

[23]  H. Ahmed,et al.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study , 2012, The Lancet. Oncology.

[24]  J. J. de la Rosette,et al.  Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. , 2008, Journal of endourology.

[25]  O. Rouvière,et al.  Détection par IRM des récidives locales du cancer de prostate après traitement par ultrasons focalisés de haute intensité (HIFU) transrectaux : étude préliminaire , 2008 .

[26]  M. Schostak,et al.  Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. , 2008, Urology.

[27]  M. Marberger.  Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation , 2007, Current opinion in urology.

[28]  T. Uchida,et al.  Transrectal high‐intensity focused ultrasound for the treatment of localized prostate cancer: Eight‐year experience , 2009, International journal of urology : official journal of the Japanese Urological Association.

[29]  H. Ahmed,et al.  Rectal fistulae after salvage high‐intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy , 2009, BJU international.

[30]  J. Chapelon,et al.  Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. , 2009, European urology.

[31]  Yipeng Hu,et al.  Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system , 2013, BJU international.

[32]  H. Ahmed,et al.  The feasibility and safety of high‐intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy , 2008, BJU international.

[33]  M. Marberger,et al.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo. , 1995, Cancer research.

[34]  S. Crouzet,et al.  Prostate focused ultrasound focal therapy—imaging for the future , 2012, Nature Reviews Clinical Oncology.

[35]  Laura Curiel,et al.  Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.

[36]  M. Marberger,et al.  Morphology of tissue destruction induced by focused ultrasound. , 1993, European urology.

[37]  Victor E Reuter,et al.  Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. , 2008, The Journal of urology.

[38]  Chris J Diederich,et al.  MRI‐guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator , 2002, Journal of magnetic resonance imaging : JMRI.

[39]  R. Miano,et al.  HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. , 2012, Urologic oncology.

[40]  C. Chaussy,et al.  Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. , 2013, The Journal of urology.

[41]  J. Chapelon,et al.  854 FOCAL THERAPY OF PROSTATE CANCER (PCA) WITH HIFU: INFLUENCE ON ERECTILE DYSFUNCTION (ED) , 2009 .

[42]  Olivier Rouvière,et al.  MRI Appearance of Prostate following Transrectal HIFU Ablation of Localized Cancer , 2001, European Urology.

[43]  A. Gross,et al.  Single application of high‐intensity focused ultrasound as a first‐line therapy for clinically localized prostate cancer: 5‐year outcomes , 2012, BJU international.

[44]  K. Asano,et al.  Transrectal high‐intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy , 2007, International journal of urology : official journal of the Japanese Urological Association.

[45]  Ian A. Donaldson,et al.  Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy. , 2014, Urology.

[46]  Bernhard Walter,et al.  First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. , 2008, European urology.

[47]  J A Smith,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[48]  Chris J Diederich,et al.  Highly directional transurethral ultrasound applicators with rotational control for MRI-guided prostatic thermal therapy. , 2004, Physics in medicine and biology.

[49]  L. Curiel,et al.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. , 2004, Urology.

[50]  P. Wild,et al.  Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer , 2006, World Journal of Urology.

[51]  Cyril Lafon,et al.  Feasibility of a transurethral ultrasound applicator for coagulation in prostate. , 2004, Ultrasound in medicine & biology.

[52]  A. Gelet,et al.  Current status of high-intensity focused ultrasound for prostate cancer: Technology, clinical outcomes, and future , 2008, Current urology reports.

[53]  H. Ahmed,et al.  Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy , 2012, Cancer.

[54]  R M Henkelman,et al.  Prostate cancer: MR imaging and thermometry during microwave thermal ablation-initial experience. , 2000, Radiology.

[55]  H. Sung,et al.  High-Intensity Focused Ultrasound as Salvage Therapy for Patients With Recurrent Prostate Cancer After Radiotherapy , 2014, Korean journal of urology.

[56]  S. Crouzet,et al.  Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[57]  P. Choyke,et al.  Magnetic resonance imaging (MRI)‐guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI‐based moulds , 2013, BJU international.

[58]  E. Barret,et al.  Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. , 2011, International braz j urol : official journal of the Brazilian Society of Urology.

[59]  D. Kuban,et al.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. , 2003, International journal of radiation oncology, biology, physics.

[60]  Rajiv Chopra,et al.  MRI-compatible transurethral ultrasound system for the treatment of localized prostate cancer using rotational control. , 2008, Medical physics.